Publications by authors named "Emiley Pham"

Claim this Profile
B
Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease.
Edward Rockenstein, Kiren Ubhi, Emiley Pham, Sarah Michael, Edith Doppler

J Neurosci Res· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo demonstration that alpha-synuclein oligomers are toxic.
Beate Winner, Roberto Jappelli, Samir K Maji, Paula A Desplats, Leah Boyer, Emiley Pham

Proc Natl Acad Sci U S A· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased BMP6 levels in the brains of Alzheimer's disease patients and APP transgenic mice are accompanied by impaired neurogenesis.
Leslie Crews, Anthony Adame, Christina Patrick, Alexandra Delaney, Emiley Pham

J Neurosci· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced hypocretin (orexin) levels in dementia with Lewy bodies.
Stephanie Lessig, Kiren Ubhi, Douglas Galasko, Anthony Adame, Emiley Pham

Neuroreport· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins.
Emiley Pham, Leslie Crews, Kiren Ubhi, Lawrence Hansen, Anthony Adame

FEBS J· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis